Literature DB >> 17905480

The transcription factor PITX3 is associated with sporadic Parkinson's disease.

Julia Fuchs1, Jakob C Mueller, Peter Lichtner, Claudia Schulte, Marita Munz, Daniela Berg, Ullrich Wüllner, Thomas Illig, Manu Sharma, Thomas Gasser.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease with typical motor symptoms due to the preferential loss of midbrain dopaminergic (mDA) neurons in the Substantia nigra pars compacta. Several proteins of the homeodomain family are crucial for the development of mDA neurons. These proteins remain expressed into adulthood with largely unknown functions, but potentially influence mDA neuronal survival. To determine whether genetic variation in these genes plays a role in sporadic PD, we performed a genetic association study in a screening sample of 340 PD patients and 680 controls and a large replication sample of 669 PD patients and 669 controls using 54 single nucleotide polymorphisms in and around the Engrailed 1/2, PITX3, LMX1B and OTX2 genes. We provide evidence for a novel, strong and reproducible association of the PITX3 promoter SNP rs3758549: C>T (p=0.004) with PD. The C-allele appears to be a recessive risk allele with an estimated population frequency of 83%. An allele-dependent dysregulation of PITX3 expression might contribute to the susceptibility to PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905480     DOI: 10.1016/j.neurobiolaging.2007.08.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  37 in total

1.  Regulation of complex I by Engrailed is complex too.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

2.  L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.

Authors:  Gale A Kleven; Heather M Booth; Marco Voogd; April E Ronca
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

Review 3.  The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease.

Authors:  Jia Li; John A Dani; Weidong Le
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 4.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

Review 5.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

6.  Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.

Authors:  Ariadna Laguna; Nicoletta Schintu; André Nobre; Alexandra Alvarsson; Nikolaos Volakakis; Jesper Kjaer Jacobsen; Marta Gómez-Galán; Elena Sopova; Eliza Joodmardi; Takashi Yoshitake; Qiaolin Deng; Jan Kehr; Johan Ericson; Per Svenningsson; Oleg Shupliakov; Thomas Perlmann
Journal:  Nat Neurosci       Date:  2015-04-27       Impact factor: 24.884

7.  Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons.

Authors:  Dong-Youn Hwang; Sunghoi Hong; Joo-Won Jeong; Sangdun Choi; Hansoo Kim; Jangwoo Kim; Kwang-Soo Kim
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

Review 8.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

9.  Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression.

Authors:  Kambiz N Alavian; Paola Sgadò; Lavinia Alberi; Srinivasa Subramaniam; Horst H Simon
Journal:  Neural Dev       Date:  2009-03-16       Impact factor: 3.842

10.  MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders.

Authors:  Olivier C Maes; Howard M Chertkow; Eugenia Wang; Hyman M Schipper
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.